Natraj Proteins Limited

As of June 30, 2026, Natraj Proteins Limited carries a market capitalization of 143.10M, placing it among publicly traded companies globally. Its enterprise value stands at 143.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Natraj Proteins Limited has 3.75M shares outstanding.

As of June 30, 2026, Natraj Proteins Limited trades at a trailing price-to-earnings ratio of 3.21.

As of June 30, 2026, Natraj Proteins Limited trades at an EV/EBITDA multiple of 2.03 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.14 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2.15 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 143.10M versus a market cap of 143.10M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 26.83M in revenue per employee across its workforce of 39.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Natraj Proteins Limited recorded an income tax benefit of -342,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 44.21M, leaving 44.55M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Natraj Proteins Limited's stock has declined approximately 5.52% over the past 52 weeks. The 50-day moving average sits at 39.55, while the 200-day moving average is 36.00.

Over the twelve months ended June 30, 2026, Natraj Proteins Limited generated 1.06B in revenue and converted that into 44.55M in net income, yielding earnings per share of 11.90. EBITDA reached 70.50M, while operating income came in at 66.41M.

Over the twelve months ended June 30, 2026, Natraj Proteins Limited posted a gross margin of 11.33, reflecting its pricing power and cost economics. The operating margin of 6.27 and net profit margin of 4.20 provide insight into operational efficiency.